SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-161906
Filing Date
2015-04-30
Accepted
2015-04-30 16:15:14
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d914010d10q.htm 10-Q 562671
2 EX-31.1 d914010dex311.htm EX-31.1 8501
3 EX-31.2 d914010dex312.htm EX-31.2 8497
4 EX-32.1 d914010dex321.htm EX-32.1 4197
  Complete submission text file 0001193125-15-161906.txt   3121508

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20150331.xml EX-101.INS 333776
6 XBRL TAXONOMY EXTENSION SCHEMA ebio-20150331.xsd EX-101.SCH 27203
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebio-20150331_cal.xml EX-101.CAL 38852
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebio-20150331_def.xml EX-101.DEF 87476
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebio-20150331_lab.xml EX-101.LAB 261143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebio-20150331_pre.xml EX-101.PRE 179334
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 15818763
SIC: 2834 Pharmaceutical Preparations